Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Central sensitization-related changes of effective and functional connectivity in the rat inflammatory trigeminal pain model.

Spisák T, Pozsgay Z, Aranyi C, Dávid S, Kocsis P, Nyitrai G, Gajári D, Emri M, Czurkó A, Kincses ZT.

Neuroscience. 2017 Mar 6;344:133-147. doi: 10.1016/j.neuroscience.2016.12.018. Epub 2016 Dec 18.

PMID:
28003158
2.

Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy.

Sápi J, Kovács L, Drexler DA, Kocsis P, Gajári D, Sápi Z.

PLoS One. 2015 Nov 5;10(11):e0142190. doi: 10.1371/journal.pone.0142190. eCollection 2015.

3.

Scopolamine provocation-based pharmacological MRI model for testing procognitive agents.

Hegedűs N, Laszy J, Gyertyán I, Kocsis P, Gajári D, Dávid S, Deli L, Pozsgay Z, Tihanyi K.

J Psychopharmacol. 2015 Apr;29(4):447-55. doi: 10.1177/0269881114565652. Epub 2015 Jan 13.

PMID:
25586394
4.

The air temperature may affect ophthalmologic emergency attendances.

Fejes I, Kocsis PB, Janáky M, Facskó A.

Acta Ophthalmol. 2015 Jun;93(4):e311-3. doi: 10.1111/aos.12497. Epub 2014 Jul 10. No abstract available.

5.

Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats.

Sárvári M, Deli L, Kocsis P, Márk L, Maász G, Hrabovszky E, Kalló I, Gajári D, Vastagh C, Sümegi B, Tihanyi K, Liposits Z.

Brain Res. 2014 Oct 2;1583:1-11. doi: 10.1016/j.brainres.2014.06.020. Epub 2014 Jun 26.

PMID:
24976584
6.

Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the rat.

Sárvári M, Kocsis P, Deli L, Gajári D, Dávid S, Pozsgay Z, Hegedűs N, Tihanyi K, Liposits Z.

PLoS One. 2014 May 15;9(5):e97651. doi: 10.1371/journal.pone.0097651. eCollection 2014.

7.

Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study.

Kocsis P, Gyertyán I, Éles J, Laszy J, Hegedűs N, Gajári D, Deli L, Pozsgay Z, Dávid S, Tihanyi K.

J Cereb Blood Flow Metab. 2014 Jun;34(6):995-1000. doi: 10.1038/jcbfm.2014.47. Epub 2014 Mar 19.

8.

Interocular amplitude and latency differences of pattern ERG and pattern VEP parameters.

Fejes I, Kocsis PB, Benedek G, Janáky M.

Optom Vis Sci. 2014 Apr;91(4):472-6. doi: 10.1097/OPX.0000000000000193.

PMID:
24492757
9.

Effect of tolperisone on the resting brain and on evoked responses, an phMRI BOLD study.

Kocsis P, Gajári D, Deli L, Gőcze KZ, Pozsgay Z, Tihanyi K.

Brain Res Bull. 2013 Oct;99:34-40. doi: 10.1016/j.brainresbull.2013.09.008. Epub 2013 Oct 4.

PMID:
24099980
10.

Kinetic bacteriochlorophyll fluorometer.

Kocsis P, Asztalos E, Gingl Z, Maróti P.

Photosynth Res. 2010 Jul;105(1):73-82. doi: 10.1007/s11120-010-9556-6. Epub 2010 May 8.

PMID:
20454858
11.

Recent advancements in anti-migraine drug research: focus on attempts to decrease neuronal hyperexcitability.

Bölcskei H, Farkas B, Kocsis P, Tarnawa I.

Recent Pat CNS Drug Discov. 2009 Jan;4(1):14-36. Review.

PMID:
19149711
12.

Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.

Tarnawa I, Bölcskei H, Kocsis P.

Recent Pat CNS Drug Discov. 2007 Jan;2(1):57-78. Review.

PMID:
18221218
13.

Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: Possible use in the therapy of spasticity and chronic pain.

Thán M, Kocsis P, Tihanyi K, Fodor L, Farkas B, Kovács G, Kis-Varga A, Szombathelyi Z, Tarnawa I.

Neurochem Int. 2007 Mar;50(4):642-52. Epub 2007 Jan 13.

PMID:
17280740
14.

Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.

Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I.

J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. Epub 2005 Aug 26.

PMID:
16126840
15.

Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs.

Farkas S, Berzsenyi P, Kárpáti E, Kocsis P, Tarnawa I.

J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):264-73. Epub 2005 Jan 12.

PMID:
16125625
16.

NR2B receptors are involved in the mediation of spinal segmental reflex potentials but not in the cumulative motoneuronal depolarization in vitro.

Kocsis P, Kovács G, Farkas S, Horváth C, Szombathelyi Z, Tarnawa I.

Brain Res Bull. 2004 Aug 30;64(2):133-8.

PMID:
15342100
17.

NR2B containing NMDA receptor dependent windup of single spinal neurons.

Kovács G, Kocsis P, Tarnawa I, Horváth C, Szombathelyi Z, Farkas S.

Neuropharmacology. 2004 Jan;46(1):23-30.

PMID:
14654094
18.

Participation of AMPA- and NMDA-type excitatory amino acid receptors in the spinal reflex transmission, in rat.

Kocsis P, Tarnawa I, Szombathelyi Z, Farkas S.

Brain Res Bull. 2003 Apr 15;60(1-2):81-91.

PMID:
12725896
19.

[Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].

Kocsis P, Tarnawa I, Kovács G, Szombathelyi Z, Farkas S.

Acta Pharm Hung. 2002;72(1):49-61. Hungarian.

PMID:
12426787
20.

Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum.

Világi I, Kocsis P, Tarnawa I, Banczerowski-Pelyhe I.

Brain Res Bull. 1998 Aug;46(6):483-6.

PMID:
9744284
21.

Participation of NMDA and AMPA type glutamate receptors in spinal segmental reflex: an in vitro study.

Kocsis P, Farkas S, Bielik N.

Neurobiology (Bp). 1997;5(1):71-3. No abstract available.

PMID:
9302702
22.
23.

Studies on the mechanism of action of RGH-5002, a centrally acting muscle relaxant, using whole cell patch clamp technique.

Bielik N, Farkas S, Kocsis P.

Neurobiology (Bp). 1997;5(1):43-5. No abstract available.

PMID:
9302694
24.

The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders.

Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, et al.

JAMA. 1991 Oct 2;266(13):1793-800.

PMID:
1832466

Supplemental Content

Loading ...
Support Center